Edition:
United States

Joint Corp (JYNT.OQ)

JYNT.OQ on NASDAQ Stock Exchange Capital Market

8.06USD
16 Nov 2018
Change (% chg)

$-0.17 (-2.07%)
Prev Close
$8.23
Open
$8.11
Day's High
$8.25
Day's Low
$8.06
Volume
2,991
Avg. Vol
7,576
52-wk High
$9.53
52-wk Low
$4.70

Latest Key Developments (Source: Significant Developments)

Joint Q3 Loss Per Share $0.01
Thursday, 8 Nov 2018 04:05pm EST 

Joint Corp ::THE JOINT CORP. REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.01.SEES FY 2018 REVENUE $31 MILLION TO $32 MILLION.Q3 REVENUE $8.1 MILLION VERSUS I/B/E/S VIEW $8 MILLION.Q3 EARNINGS PER SHARE VIEW $0.01 -- THOMSON REUTERS I/B/E/S.2018 ADJUSTED EBITDA INCOME IS EXPECTED TO RANGE BETWEEN $2.5 MILLION AND $3.5 MILLION.  Full Article

Joint Corp Board Appointed Peter Holt To Serve As Interim Principal Financial Officer
Thursday, 9 Aug 2018 04:27pm EDT 

Aug 9 (Reuters) - Joint Corp ::BOARD APPOINTED PETER D. HOLT TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER UNTIL CO COMPLETES ITS SEARCH FOR A REPLACEMENT CFO.  Full Article

Joint Q2 Earnings Per Share $0.00
Thursday, 9 Aug 2018 04:05pm EDT 

Joint Corp ::THE JOINT CORP. REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.00.Q2 EARNINGS PER SHARE VIEW $-0.01 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $31 MILLION TO $32 MILLION.Q2 REVENUE $7.6 MILLION VERSUS I/B/E/S VIEW $7.6 MILLION.SEES FY 2018 TOTAL EXPECTED NEW CLINIC OPENINGS TO BE IN RANGE OF 40 TO 52.FY2018 REVENUE VIEW $31.4 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Joint Qtrly Loss Per Share $0.02‍​
Thursday, 8 Mar 2018 04:05pm EST 

March 8 (Reuters) - Joint Corp ::THE JOINT CORP. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.SEES FY 2018 REVENUE $31 MILLION TO $32 MILLION.QTRLY ‍REVENUE GREW 20% TO $6.9 MILLION, COMPARED TO $5.8 MILLION IN Q4 OF 2016​.QTRLY LOSS PER SHARE $0.02‍​.‍ADJUSTED EBITDA FOR FY 2018 IS EXPECTED TO RANGE BETWEEN $2.5 MILLION AND $3.5 MILLION​.‍AS OF DECEMBER 31, 2017, CASH AND CASH EQUIVALENTS WERE $4.2 MILLION, COMPARED TO $3.0 MILLION AT DECEMBER 31, 2016​.‍TOTAL NEW CLINIC OPENINGS IN FY 2018 ARE EXPECTED TO BE IN RANGE OF 40 TO 52​.  Full Article

Joint posts Q3 loss per share $0.03​
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Joint Corp :The Joint Corp reports third quarter 2017 financial results.Q3 revenue $6.5 million versus I/B/E/S view $6.2 million.Sees FY 2017 revenue $24 million to $26 million.Joint Corp - qtrly ‍basic and diluted loss per share $0.03​.Joint Corp - ‍ total revenues are now expected to be between $24 million and $26 million for full year 2017​.Joint Corp - ‍adjusted EBITDA is expected to range between a loss of $0.5 million to a gain of $0.5 million for full year 2017​.  Full Article

Joint Corp reports Q2 loss per share $0.08
Thursday, 10 Aug 2017 04:00pm EDT 

Aug 10 (Reuters) - Joint Corp -:The Joint Corp reports second quarter 2017 financial results.Q2 loss per share $0.08.Q2 revenue $6.0 million versus I/B/E/S view $5.7 million.Q2 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $22 million to $24 million.Joint Corp - ‍reaffirmed 2017 guidance​.Joint Corp says reiterating guidance for FY.Fy2017 revenue view $23.9 million -- Thomson Reuters I/B/E/S.  Full Article

Joint Corp reports Q1 loss per share $0.13
Thursday, 11 May 2017 04:01pm EDT 

May 11 (Reuters) - Joint Corp :Reports first quarter 2017 financial results.Q1 loss per share $0.13.Q1 revenue rose 33 percent to $5.7 million.Sees fy 2017 revenue $22 million to $24 million.  Full Article

Glenhill Advisors LLC reports 17.2 pct stake in Joint Corp as on March 24 - SEC Filing
Monday, 3 Apr 2017 04:59pm EDT 

Joint Corp :Glenhill Advisors LLC reports 17.2 percent stake in Joint Corp as on March 24, 2017 - SEC Filing.  Full Article

Joint Q4 loss per share $0.45
Thursday, 9 Mar 2017 04:00pm EST 

Joint Corp : The Joint Corp reports fourth quarter and full year 2016 financial results . Q4 loss per share $0.45 . Q4 revenue rose 54 percent to $5.8 million . Sees FY 2017 revenue $22 million to $24 million . Working towards achieving company-wide adjusted EBITDA breakeven during first half of 2017 . Joint Corp sees in 2017 net new franchise clinic openings in range of 50 to 60 .Joint Corp - sees FY adjusted EBITDA to be negative in range of $1.5 million to $0.5 million.  Full Article

Joint Corp says entered credit and security agreement with Tower 7 Partnership
Monday, 9 Jan 2017 07:45am EST 

Joint Corp : Joint - on jan 3, 2017, entered credit and security agreement with tower 7 partnership llc,signed revolving credit note payable to lender - sec filing . Joint corp - under credit agreement, company is able to borrow up to an aggregate of $5 million under revolving loans .Joint corp - interest on unpaid outstanding principal amount of any revolving loans is at a rate equal to 10% per annum.  Full Article